In another study, the antiproliferative effect of TAE684, a potent second generation ALK inhibitor that overcomes crizotinib resistance, was augmented by radiotherapy in EML4-ALK positive lung cancer cells [20]. This evidence concerns the gene ALK and lung cancer.